Ryosuke Yoshida

A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression

Yasumoto Yamasaki, Hiroshi Tazawa, Yuuri Hashimoto et al. · European Journal of Cancer · 2012 · 59 citations

Life Sciences, Molecular Biology, Oncology +17

Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1‐<i>microRNA‐7‐</i>epidermal growth factor receptor axis

Hiroshi Tazawa, Shuya Yano, Ryosuke Yoshida et al. · International Journal of Cancer · 2012 · 53 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas

Tsuyoshi Sasaki, Hiroshi Tazawa, Joe Hasei et al. · Clinical Cancer Research · 2011 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +17

Remarkable interaction effects of molecular packing on site- and stereoselectivity in photocycloaddition of 2-pyrones with maleimide in the solid state

Toru Obata, Tetsuro Shimo, M. Yasutake et al. · Tetrahedron · 2001 · 31 citations

Natural Sciences, Chemical Engineering, Chemistry +13

Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells

Ryosuke Yoshida, Hiroshi Tazawa, Yuuri Hashimoto et al. · Cancer Immunology Immunotherapy · 2012 · 26 citations · Full text

Medicine, Molecular Biology, Oncology +17